General Biosystems, Inc.
PrivateLast Round
Growth Equity
Jun 29, 2022
Total Funding Raised
$14.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
General Biosystems, Inc. operates in Healthcare & Life Sciences and is based in Morrisville, North Carolina. Its latest recorded funding round was a Growth Equity round in June 2022.
General Biosystems, Inc. is a biotechnology company that provides synthetic biology services, including gene synthesis, protein expression, and molecular biology solutions for research and development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
General Biosystems, Inc. Comparables
Compare General Biosystems, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Azenta, Inc. | 76% | |
| Twist Bioscience Corporation | 74% | |
| Thermo Fisher Scientific Inc. | 73% |
For institutional investors. Book with your work email.
General Biosystems, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jun 29, 2022 | ||||
| Series A | Apr 28, 2021 |
For institutional investors. Book with your work email.
General Biosystems, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jifeng Ventures | Series A |
| Zhejiang Sino Wisdom Investment Management | Growth Equity |
| 华义创投 (Huayi Venture Capital) | Series A |
| Addor Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 60% MoM, reaching 2.7K.
- Jun 19, 2026
Monthly visitors grew 81% MoM, from 1.8K to 3.2K.
For institutional investors. Book with your work email.
General Biosystems, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about General Biosystems, Inc.'s valuation, stock price, and market status.
Is General Biosystems, Inc. a public or private company?
General Biosystems, Inc. is a private company.
What is the current stock price of General Biosystems, Inc.?
General Biosystems, Inc. is a private company, so its shares have no public market price. Caplight tracks General Biosystems, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is General Biosystems, Inc. worth (valuation)?
Valuation information for General Biosystems, Inc. is not publicly available.
Can I buy General Biosystems, Inc. stock?
General Biosystems, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was General Biosystems, Inc.'s last funding round?
General Biosystems, Inc.'s most recent funding round was Growth Equity on June 29, 2022.
Who are the main investors in General Biosystems, Inc.?
Key investors in General Biosystems, Inc. include Jifeng Ventures, Zhejiang Sino Wisdom Investment Management.
Will General Biosystems, Inc. IPO soon?
No public IPO plans have been announced for General Biosystems, Inc..
How can I track General Biosystems, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in General Biosystems, Inc.'s shares on secondary markets.